You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cell Division

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

Not yet recruiting
  • Granulocyte Colony-Stimulating Factor
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Locally Advanced or Metastatic NSCLC Trial in Ohio City (PBF-1129)

Active, not recruiting
  • Locally Advanced or Metastatic NSCLC
  • Ohio City, Ohio
    Division of medical Oncology A450B Starling Loving Hall
Jan 24, 2023

NSCLC Trial in Munich (Bone marrow aspiration from the iliac crest, Illinois bone marrow aspiration neddle)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Bone marrow aspiration from the iliac crest
  • Illinois bone marrow aspiration neddle
  • Munich, Germany
    Division of Thoracic Surgery, Technical University of Munich, Mu
May 16, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

Active, not recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Madrid, Spain
  • +1 more
Jul 1, 2022

Type 1 Diabetes Trial in United States (Siplizumab)

Not yet recruiting
  • Type 1 Diabetes Mellitus
  • Birmingham, Alabama
  • +19 more
Jan 25, 2023

Perianal Fistula in Patients With Crohn's Disease Trial in Tehran (placenal MSC derived exosomes)

Active, not recruiting
  • Perianal Fistula in Patients With Crohn's Disease
  • placenal MSC derived exosomes
  • Tehran, Iran, Islamic Republic of
    Division of Colorectal Surgery, Department of Surgery, Tehran Un
Aug 11, 2022

Pleural Effusion Trial in Jakarta Pusat (procedure, diagnostic test, drug)

Not yet recruiting
  • Pleural Effusion
  • Medical thoracoscopy
  • +2 more
  • Jakarta Pusat, DKI Jakarta, Indonesia
    Respirology and Critical Illness Division, Department of Interna
Sep 21, 2022

Multiple Myeloma Trial in Torino (Cyclophosphamide, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    Division of Hematology, Molinette Hospital
Apr 6, 2022

Development of a Method To Detect Dendritic Cells

Not yet recruiting
  • Probable Alzheimer's Disease
    • Long Beach, California
      CNS, A Division of APEX Innovative Sciences
    Aug 15, 2022

    NSCLC, Lung Cancer, NSCLC Trial in United States (G1T38, Osimertinib)

    Completed
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • Beverly Hills, California
    • +7 more
    Sep 20, 2022

    Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

    Recruiting
    • Relapsing Multiple Sclerosis
    • +2 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • Best Available Therapy (BAT)
    • Palo Alto, California
    • +20 more
    Jan 25, 2023

    Natural History Study of GATA2 Deficiency and Related Disorders

    Recruiting
    • GATA2 Deficiency
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      GVHD in GI Tract Trial in Graz (Fecal microbiota transplantation)

      Recruiting
      • Graft Versus Host Disease in GI Tract
      • Fecal microbiota transplantation
      • Graz, Styria, Austria
        Division of Gastroenterology and Hepatology, Department of Inter
      Apr 5, 2022

      Breast, Prostate, Colorectal, Liver, or Kidney Cancer or

      Recruiting
      • Breast Carcinoma
      • +7 more
      • Biospecimen Collection
      • Laboratory Biomarker Analysis
      • Rockville, Maryland
        National Cancer Institute Division of Cancer Prevention
      Jun 29, 2022

      Biobank, Treatment Response and Outcome Predictor

      Recruiting
      • Coronavirus Infections
      • Observational Study
      • Milan, Lombardy, Italy
      • +12 more
      Dec 23, 2022

      Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab, Polatuzumab vedotin, Tocilizumab)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Buenos Aires, Argentina
      • +18 more
      Aug 10, 2022

      Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

      Recruiting
      • Non Small Cell Lung Cancer
      • +6 more
      • Scottsdale, Arizona
      • +4 more
      Dec 27, 2022

      Multiple Myeloma, Newly Diagnosed Patients Trial in Torino (Melphalan, Lenalidomide, Prednisone)

      Active, not recruiting
      • Multiple Myeloma
      • Newly Diagnosed Patients
      • Torino, Italy
        Division of Hematology, AOU Città della Salute e della Scienza d
      Mar 24, 2022

      Nonhematologic Tumors, Advanced Trial in Kashiwa, Chuo-ku (TAK-931)

      Completed
      Has Results
      • Nonhematologic Neoplasms, Advanced
      • Kashiwa, Chiba, Japan
      • +1 more
      Feb 2, 2021

      SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19

      Completed
      • SARS-CoV Infection
      • +3 more
      • Moderna COVID-19 Vaccine
      • +2 more
      • Tucson, Arizona
      • +28 more
      Sep 19, 2022

      Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

      Recruiting
      • Rheumatoid Arthritis
      • +8 more
      • Moderna mRNA-1273
      • +5 more
      • Los Angeles, California
      • +24 more
      Aug 17, 2022

      Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States

      Not yet recruiting
      • Esophageal Adenocarcinoma
      • +2 more
      • Palo Alto, California
      • +5 more
      Jan 12, 2023

      Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis

      Withdrawn
      • Lymphoma, T-Cell, Cutaneous
      • Mycosis Fungoides/Sezary Syndrome
      • Zürich, Switzerland
        UniversitaetsSpital Zurich - Division of Dermatology
      Aug 31, 2021

      Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

      Recruiting
      • Acute Myeloid Leukemia (AML) in Remission
      • Stem Cell Transplantation
      • busulfan, cyclophosphamide and melphalan, BuCyMel
      • clofarabine, fludarabine and busulfan, CloFluBu
      • Brussels, Belgium
      • +16 more
      Jul 25, 2022

      Lung Transplant Trial in United States (Rituximab (Rituxan®), Placebo)

      Completed
      Has Results
      • Lung Transplant
      • Rituximab (Rituxan®)
      • Placebo
      • Palo Alto, California
      • +6 more
      Oct 7, 2021